(Q43606941)

English

Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

secondary progressive multiple sclerosis

0 references

multiple sclerosis

0 references

author name string

J Furby

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

T Hayton

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

V Anderson

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

D Altmann

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R Brenner

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J Chataway

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Rac Hughes

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kj Smith

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Dh Miller

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R Kapoor

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1068-1075

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Optimizing the association between disability and biological markers in MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Eight-year follow-up study of brain atrophy in patients with MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Magnetic resonance imaging measures of brain atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

A semiautomated measure of whole-brain atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Multimodal image coregistration and partitioning--a unified framework.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1352458508093617

21 January 2018

Identifiers

10.1177/1352458508093617

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43606941&oldid=2101864623"